Tick-borne encephalitis is a significant concern in endemic regions, and in rare cases it may even be fatal. There is no specific treatment for the disease. Vaccines from two manufacturers are available against tick-borne encephalitis, both considered effective and safe. Severe adverse effects due to tick-borne encephalitis vaccine are rare. We describe the first severe myelitis detected in Finland following vaccination against tick-borne encephalitis.